Excellus BlueCross BlueShield partnering with Civica to increase access to affordable insulin

Posted on March 2, 2022

News Release

 

For Immediate Release                                                                                 Contact: Karen Feigel

Date: March 3, 2022                                                                                                       (585) 238-4308


Excellus BlueCross BlueShield partnering with Civica

to increase access to affordable insulin

Civica to manufacture and distribute three insulins for $30 or less per vial


ROCHESTER, NY - Today, Excellus BlueCross BlueShield, the Blue Cross Blue Shield Association (BCBSA) and other Blue Cross and Blue Shield (BCBS) companies joined Civica’s initiative to manufacture and distribute affordable insulins that, once approved, will be available to people living with diabetes at significantly lower prices than insulins currently on the market. The medications are expected to be available to all consumers for $30 or less per vial starting in 2024.

 

Excellus BCBS, BCBSA and BCBS companies are collaborating on this initiative with Civica and other partners across the health care industry, representing nearly every corner of the diabetes ecosystem.

 

“We’re proud to be part of this national collaboration to bring more affordable insulin and other medications to our communities,” said Mona Chitre, Pharm.D., chief pharmacy officer and vice president of Integrated Health Strategy for Excellus BCBS. “The Civica initiative will help us fulfill our critical role of controlling rising health care costs while also ensuring that more patients take their medication as prescribed since their prescription drugs will now be more affordable.”

 

“This is an important milestone in our continued partnership with Civica as we advance our shared goal of bringing lower-cost prescription medication directly to consumers,” said Kim Keck, president and CEO of BCBSA. “Access to affordable insulin can be the difference between life and death for diabetics – and we’re proud to be a part of Civica’s effort to ensure that millions of Americans have access to the medicine they need at a price they can afford. When we come together, we can make health care more affordable.”

More than eight million Americans rely on insulin to live, but as many as one in four insulin users report having to skip doses or take less than prescribed amounts due to the high cost of the medicine.[1] The financial burden has made the drug inaccessible for many and has led to patients developing health conditions that were once preventable.

 

Through this initiative, Civica will manufacture and distribute three analog insulins – glargine, lispro and aspart – which will be biosimilar drugs of the brand-name insulins Lantus, Humalog and Novolog. The insulins will be available in vials and prefilled pens at no more than $30 per vial or $55 for a box of five pens.

 

“Diabetes is arguably America’s most expensive chronic condition, and it is heartbreaking that millions

 

–more–

 

News release: Excellus BlueCross BlueShield Partnering with Civica – page 2

 

of people are rationing their care and putting their lives at risk because they can no longer afford insulin,” said Dan Liljenquist, board chair of Civica. “Through mission-driven partnerships, we are choosing to create a new market reality where no one is forced to ration essential diabetes medications.”

 

This insulin initiative is one of the many ways BCBS companies are partnering with Civica to increase access to safe and affordable medications. This announcement follows the founding of Civica’s subsidiary, CivicaScript, by BCBSA, 18 BCBS companies and Civica Rx to develop and manufacture common generic medications for which there is currently not enough market competition to drive down prices. The first of these lower-cost generic prescriptions are expected to be available to consumers through specialty and home delivery pharmacies later this year.

 

For more information on the insulin initiative, visit https://civicainsulin.org. For more information on CivicaScript, visit: https://www.bcbs.com/civica-rx.

 

 

###

 

About Excellus BlueCross BlueShield
Excellus BlueCross BlueShield, an independent licensee of the Blue Cross Blue Shield Association, is a nonprofit health plan with 1.5 million upstate New York members. The company's mission is to help people live healthier and more secure lives through access to high-quality, affordable health care. Its products and services include cost-saving prescription drug discounts, wellness tracking tools and access to telemedicine. With more than 3,500 employees, the company is committed to attracting and retaining a diverse workforce to foster innovation and better serve its members. It also encourages employees to engage in their communities by providing paid volunteer time off as one of many benefits. To learn more, visit
ExcellusBCBS.com.

About the Blue Cross Blue Shield Association
The Blue Cross and Blue Shield Association is a national federation of 34 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide health care coverage for one in three Americans.

[1] JAMA, Cost-Related Insulin Underuse Among Patients with Diabetes, 2019

Other Member News

February 29, 2024

Fundamentals of Working with the Media

This interactive presentation will cover the fundamentals of working with the news media.

February 28, 2024

Dannible & McKee LLP Recommends Filing Taxes Early and Electronically

Tax season is in full swing and now is the time to file your taxes.

Fast Track to Small Business Start-Up
February 28, 2024

Fast Track to Small Business Start-Up Virtual Webinar

The workshop includes a variety of presenters who are all experts in different facets of small business start-up.

New CNAs graduate from Oswego Health's training program
February 27, 2024

Seven New CNAs Graduate from Oswego Health’s On-the-Job Training Program at The Manor

The Manor at Seneca Hill makes starting a career in healthcare easy with on-the-job training and a paid certification program.  

Cayuga St. Steakhouse Murder Mystery Dinner
February 26, 2024

Cayuga St. Steakhouse Murder Mystery Dinner

Get all the details here.

Attend the CNY Women's Summit at the Oncenter!
February 23, 2024

Attend the CNY Women's Summit at the Oncenter!

See all the details here.

Dr. Lynn-Beth Satterly
February 20, 2024

Liberty Resources Welcomes Dr. Lynn-Beth Satterly to its Primary Care Practice

In this role, Dr. Satterly will provide comprehensive care in collaboration with an integrated health team.

Suzanne Benderski
February 16, 2024

CPS Recruitment Announces Staff Promotion

Benderski has been an integral part of CPS Recruitment since joining the firm in 2011. 

Excellus BCBS logo
February 16, 2024

Forbes Names Excellus BlueCross BlueShield #8 on List of Best Midsize Employers in America

This is the second consecutive year that Excellus BCBS has been named to the list.